AmoxyMir-CV 625 is a combination antibiotic formulation containing Amoxicillin 500 mg + Potassium Clavulanate 125 mg, used for the treatment of susceptible bacterial infections.

Formulation: Amoxicillin 500 mg + Potassium Clavulanate 125 mg
Packaging: 10 × 1 × 10 Alu-Alu Tablets

Product Description:
AmoxyMir-CV 625 combines Amoxicillin, a penicillin-class antibiotic, with Potassium Clavulanate, which helps overcome resistance caused by certain bacterial beta-lactamases. The combination is used to treat a range of susceptible bacterial infections and should be taken only as prescribed by a qualified healthcare professional.